Bonora, Stefano <br/><br/>
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.  [electronic resource] 

 -  Antiviral therapy  2011 
 - 499-504 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2040-2058 
<br/><br/><label>Standard No.: </label>10.3851/IMP1802  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Atazanavir Sulfate<br/>Deoxycytidine--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Emtricitabine<br/>HIV Seropositivity--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Oligopeptides--administration & dosage<br/>Organophosphonates--administration & dosage<br/>Pyridines--administration & dosage<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Tenofovir<br/>Treatment Outcome